Target Name: MIR554
NCBI ID: G693139
Review Report on MIR554 Target / Biomarker Content of Review Report on MIR554 Target / Biomarker
MIR554
Other Name(s): hsa-miR-554 | MIRN554 | microRNA 554 | MicroRNA 554 | hsa-mir-554

MIR554: A Potential Drug Target and Biomarker

Molecular Intelligence and Review

MIR554, also known as hsa-miR-554, is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a microRNA (miRNA), a small non-coding RNA molecule that plays a critical role in regulating gene expression. MIR554 is a part of the hsa-miR family, which consists of 20 non-coding RNAs that have been shown to play important roles in various biological processes.

MIR554 is a unique molecule due to its unique structure and biology. It is 24 amino acids long and has a unique 5' end that consists of a single amino acid, which is not typical for miRNAs. Additionally, MIR554 has a unique 3' end that is composed of a double helix, which is also not typical for miRNAs. The double helix in the 3' end is composed of a G-Crichardson base, which is a common base in RNA secondary structure, and a C-richardson base, which is not typically found in miRNAs.

MIR554 has been shown to play a critical role in various biological processes, including cell growth, cell cycle progression, and apoptosis. It has also been shown to be involved in the regulation of cell adhesion, angiogenesis, and tissue repair. In addition, MIR554 has been shown to be involved in the regulation of cellular processes such as cell signaling, DNA replication, and metabolism.

Given its unique structure and biology, MIR554 has potential as a drug target. One approach to targeting MIR554 is to use small molecules that can interact with its unique 3' end. This would involve identifying small molecules that can bind to the double helix in the 3' end of MIR554 and prevent it from being translated into a functional RNA molecule. This approach has been used to target other miRNAs, such as hsa-miR-181, which is involved in the regulation of cell adhesion and has been shown to be a potential drug target.

Another approach to targeting MIR554 is to use antibodies that recognize its unique structure. This would involve creating antibodies that recognize the unique 5' and 3' ends of MIR554 and use them to block its translation into a functional RNA molecule. This approach has been used to target other miRNAs, such as hsa-miR-181, which has been shown to be involved in the regulation of cell adhesion and has potential as a drug target.

MIR554 has also been shown to be a potential biomarker for various diseases, including cancer. One approach to using MIR554 as a biomarker is to use it as a gene expression marker to diagnose or monitor the progression of cancer. This can be done by using RNA sequencing (RNA-seq) to compare the expression levels of MIR554 in cancer cells to those in normal cells. This approach has been used to identify potential biomarkers for various diseases, including cancer.

In conclusion, MIR554 is a unique and potential drug target and biomarker. Its unique structure and biology make it an attractive target for small molecules and antibodies. Further research is needed to fully understand the role of MIR554 in various biological processes and to develop effective strategies for targeting it.

Protein Name: MicroRNA 554

The "MIR554 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR554 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR555 | MIR556 | MIR557 | MIR5571 | MIR5572 | MIR5579 | MIR558 | MIR5580 | MIR5581 | MIR5582 | MIR5583-1 | MIR5584 | MIR5585 | MIR5586 | MIR5587 | MIR5588 | MIR5589 | MIR559 | MIR5590 | MIR5591 | MIR561 | MIR562 | MIR563 | MIR564 | MIR566 | MIR567 | MIR568 | MIR5680 | MIR5681A | MIR5681B | MIR5682 | MIR5683 | MIR5684 | MIR5685 | MIR5687 | MIR5688 | MIR5689 | MIR569 | MIR5690 | MIR5691 | MIR5692A1 | MIR5692A2 | MIR5692B | MIR5692C1 | MIR5692C2 | MIR5693 | MIR5694 | MIR5695 | MIR5696 | MIR5697 | MIR5698 | MIR5699 | MIR570 | MIR5700 | MIR5701-1 | MIR5701-2 | MIR5701-3 | MIR5702 | MIR5703 | MIR5704 | MIR5705 | MIR5706 | MIR5707 | MIR5708 | MIR570HG | MIR571 | MIR572 | MIR573 | MIR5739 | MIR574 | MIR575 | MIR576 | MIR577 | MIR578 | MIR5787 | MIR579 | MIR580 | MIR581 | MIR582 | MIR583 | MIR584 | MIR585 | MIR586 | MIR587 | MIR588 | MIR589 | MIR590 | MIR591 | MIR592 | MIR593 | MIR595 | MIR596 | MIR597 | MIR598 | MIR599 | MIR600 | MIR600HG | MIR601 | MIR602 | MIR603